$RSSS

Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results

Research Solutions, Inc. (RSSS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million HENDERSON, Nev., September 9, 2026 — Research Solutions, Inc. (NASDAQ

Original reporting
Published Sep 9, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RSSS
Neutral
medium confidence
Mentioned
$RSSS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RSSSNeutralMed
01

Why it matters

The earnings release provides fresh data on revenue mix shift, margin expansion, and cash position, informing short‑term trading decisions.

02

Market read

Primary earnings disclosure for a micro‑cap tech stock; relevance driven by ARR growth and margin improvement.

03

What to watch

Potential upcoming AI product pipeline in FY27 could drive future upside not reflected in current numbers.

Relevance 7/10Novelty 8/10Timing: post‑market Sep 9 2026

Background

Research Solutions, Inc. (NASDAQ: RSSS) filed an 8‑K reporting its Q4 and full‑year 2026 financials, emphasizing AI‑related ARR growth and a record adjusted EBITDA.

Company-level read

Ticker impact

$RSSSNeutralMedium confidence
Context

SEC 8‑K reports Q4 and FY 2026 results, including net income of $2.8 M and ARR of $22.5 M.

Expected impact

Potential modest upside if investors value the ARR acceleration and AI product pipeline.

Evidence & confidence

Revenue fell slightly year‑over‑year, but margin expansion and AI‑related ARR growth suggest upside potential.

Market effects

Highlights growing AI‑driven demand in research‑workflow platforms, may benefit peers.

Limited to US tech micro‑cap space.

Low; primarily a company‑specific earnings release.

Counterpoint

Revenue decline and cash flow pressure could outweigh AI ARR growth, leading to short‑term weakness.

Key entities

  • Research Solutions, Inc.

    AI‑powered research workflow platform reporting FY2026 results.

  • Roy W. Olivier

    President & CEO who commented on AI product launches and M&A strategy.

Related articles

$RSSSMed

Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results

Research Solutions (RSSS) reported fiscal Q4 2026 revenue of $12.1M, down from $12.4M YoY. Full-year revenue was $48.3M, slightly below prior year's $49.1M. Net income rose to $2.8M for the year, up from $1.3M. B2B ARR grew 14% YoY to $16.2M, with AI-related ARR up 125% sequentially. Gross margin improved to 53% in Q4 and 51.9% for the year, driven by platform revenue growth.

$LITEHighAI 9/10

Lumentum Stock Gains After $5 Billion Co-Packaged Optics Win

Lumentum Holdings (LITE) reported fiscal Q1 revenue of $1.263B, up 136.5% YoY, beating estimates. Non-GAAP EPS was $4.57, above consensus. Systems and components revenue surged, with strong margin expansion. The company secured a $5B optics win and guided Q2 revenue to $1.575B-$1.625B, with non-GAAP EPS of $5.90-$6.20.

MedAI 8/10

JBT Marel Q3 2026 slides: record margins offset revenue miss

JBT Marel reported Q3 2026 revenue of $994M, missing expectations by $36M, but achieved record adjusted EBITDA of $179M with an 18% margin. Shares rose 2.76% to $117.95. The company raised full-year EBITDA margin and EPS guidance, citing cost synergies and share buybacks. Protein Solutions grew 6%, while Prepared Food and Beverage Solutions declined 6%.

$XPROMedAI 8/10

Expro Q3 2026 slides show strong cash flow amid execution challenges

Expro Group Holdings (XPRO) reported Q3 2026 revenue of $440M, up 11% YoY, and adjusted EBITDA of $91M, up 20% sequentially. Despite a 32% EPS miss, shares fell 14.59%. The company raised full-year free cash flow guidance to $140M-$150M and provided initial 2027 outlook. Revenue growth was driven by acquisitions and higher activity levels, while margins expanded to 20.7%.